<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Digoxin

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jun 2015Publisher:Elsevier BVJournal:Journal of the American College of Cardiology, volume 65, pages 2,699-2,701 (issn: 0735-1097,

Authors: Todd F. Dardas; Wayne C. Levy;

doi: 10.1016/j.jacc.2015.04.044

pmid: 26112192

Digoxin

- Summary
- Subjects
- Metrics

Abstract

The digitalis glycosides (digoxin) have been ensconced by history, efficacy, therapeutic necessity, and lack of definitive evidence as treatments for both heart failure (HF) and atrial fibrillation (AF). There is a reluctance to abandon digoxin because of its perceived ability to additively improve

Related Organizations

Washington State University
United States
HEARTWARE, INC.
University of Mary
United States

Keywords

Male, heart failure, Digoxin, Atrial Fibrillation, Humans, atrial fibrillation, Female, digoxin, Cardiology and Cardiovascular Medicine

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average